EZH2 inhibitor tazemetostat voluntarily withdrawn from market

Cancer 2026

View at publisher

Authors: Leah Lawrence

DOI: 10.1002/cncr.70454

Cited by: 1

References: 4

Fields of Study & Subjects

Chemical Reactions and Isotopes Pharmaceutical studies and practices Biomedical Ethics and Regulation

References 4